Spiru L

References (1)

Title : Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial - Dubois_2023_Alzheimers.Res.Ther_15_39
Author(s) : Dubois B , Lopez-Arrieta J , Lipschitz S , Triantafyllos D , Spiru L , Moroz S , Venger O , Vermersch P , Moussy A , Mansfield CD , Hermine O , Tsolaki M
Ref : Alzheimers Res Ther , 15 :39 , 2023
Abstract : Dubois_2023_Alzheimers.Res.Ther_15_39
ESTHER : Dubois_2023_Alzheimers.Res.Ther_15_39
PubMedSearch : Dubois_2023_Alzheimers.Res.Ther_15_39
PubMedID: 36849969